Corporate News
Hansoh Pharmaceutical (3692.HK)
- The share price declined by 7.33 % during a 24‑hour period ending at 01:28 PM Central Europe on Friday, 23 October 2026.
- Current trading price is approximately HKD 33.00 per share.
- The outstanding share supply is 6.10 billion shares.
- Market capitalisation stands at HKD 193.80 billion.
- Trading volume in the last 24 hours was HKD 461.5 million.
- Since the end of the previous month, the stock has fallen 8.82 %.
- The simple moving average over the last 200 trading days is HKD 34.58.
- The 52‑week high was HKD 44.22 on 15 January 2026; the 52‑week low was HKD 28.06 on 9 June 2026.
Recent Developments
Hansoh Pharmaceutical (03692.HK) experienced a modest increase in trading activity during the morning session, with the share price rising a few percent. The rally was supported by the announcement of a licensing agreement with Roche that covers several antibody‑drug conjugate (ADC) assets. Positive clinical data presented at the European Society for Medical Oncology conference further reinforced investor confidence.
Analysts at CMBI and UBS raised their price targets for the company, citing the partnership with Roche and the potential for future milestone payments.
During the same day, the Hang Seng Index fell nearly 700 points, reflecting a broader sell‑off across technology and pharmaceutical names. Hansoh’s performance was a small outlier in an otherwise weak market day.
Related Stock Movements (Past 24 Hours)
| Stock | Ticker | % Change | Current Price | Market Cap | Key Notes |
|---|---|---|---|---|---|
| Z Ai | 2513.HK | –7.1 % | HKD 499 | HKD 231 bn | - |
| Chaozhou Three‑Circle Group | 300408.SZ | 0 % | CNY 93.99 | CNY 188.7 bn | Third‑phase share‑repurchase programme (Oct) allocating CNY 2.5–5 bn. |
| Piotech | 688072.SS | 0 % | CNY 513.8 | CNY 154.3 bn | Share‑repurchase program announced; aims to improve EPS. |
| Shandong Hongqiao Aluminum | 002379.SZ | 0 % | CNY 14.01 | CNY 184.3 bn | Q3 2026 results show revenue and net‑profit growth driven by higher aluminium prices. |
| Dapustor‑UW | 301666.SZ | 0 % | CNY 390.3 | CNY 155.3 bn | Tuesday’s surge linked to strong institutional demand for advanced wafer and memory technology. |
Company Profile
Hansoh Pharmaceutical Group Co., Ltd. is a China‑based pharmaceutical company that develops and sells anti‑infectives, anti‑neoplastic agents, diabetes drugs, and other therapeutic products. The company markets its products throughout China and is listed on the Hong Kong Stock Exchange. Its corporate website is www.hspharm.com .
